Sensex

Monday, March 22, 2010

**[investwise]** Hitachi Home Targets Consumers At All Price Points With A Slew Of Launches

 

Hitachi Home (HHSL; BSE 523398) has during the year launched ACE FOLLOW ME (a feature where the cool draft of air follows the user in the room) and ACE CUT OUT (a feature of auto humidity control and it is in 0.9Tr and 1.2Tr). The company has started making its mark in the premium refrigerators market also.

 

HHLS has been changing its product mix in line with the change in customer's preferences. There has been a shift towards Split ACs (industry share has gone up to 50%) in the market place due to the narrowing of the price difference when compared to window ACs.

 

HHSL has introduced Auto Humid Control ACE Split AC, Atom Square and Quadricool to reaffirm its place as the innovative leader in the minds of the Indian consumers. The Ductable Category of products has immense growth potential and in a short period of time the company has made its mark in this segment.

 

Hitachi Home & Life Solutions (India) Limited (HHLS) is a leading manufacturer of Window ACs, Split ACs, Takumi range of Ductable Split ACs, Self contained packaged air conditioners, Set Free VRF systems and chillers. It is also marketing its range of Refrigerators and Washing Machines.

 

 

Not To forget the rural consumption

 

Emergence of retailers, nuclear families, increase in disposable incomes, growth in Tier II & III class cities all augur well for the growth of this industry.

 

Rural India's recently discovered fondness to consume everything from

shampoo to motor vehicles has introduced a very useful product segment of

Consumer Durables.

 

These consumer durables can be divided into three price baskets - a sort of equivalent of the "premium, regular and low priced" categories. Group I comprises a basket of basics like watches, radios, irons, fans etc., Group II comprises higher priced durables like television, mixers and music

systems. Group III where we have concentrated and chosen, comprises of high priced durables like air conditioners, refrigerators, microwaves to mention a few.

 

The last group appears to be in the infancy stage but is explosively growing and is also a litmus test of whether rural India is integrating into the mainstream of New India Consumerism.

 

The Indian market is fast moving towards high-end customized products, which are aesthetically designed to complement the modern households. The companies are thus concentrating to continuously innovate and come out with product variations across categories to meet the expectations of a varied class of customers.

 

In a sector where new products are being introduced with increasing frequency and the lifecycle of products getting shorter, research and

development plays an important role. Hitachi has remained at the forefront of the air-conditioning industry due to its wide range of products available in the market.

 

New technological breakthrough allows Hitachi to provide higher quality, efficient and reliable air conditioning solutions.

 

Due to intensified competition, tight liquidity scenario and demand supply

imbalances, the demand for consumer durable products has been under

pressure in the recent past. The consequent strain on margins coupled with

increased working capital and brand building investments has resulted in an

increase in borrowed funds / capital, along with fewer options to protect cash flow for most players.

 

In future the parents' commitment to their Indian venture, sustenance of their own credit profile and the ability of their subsidiaries to further improve market position will be the key factors influencing their future growth and prospects.

 



Safe Harbor Statement:

Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.
 
Nothing in this article is, or should be construed as, investment advice.
 
 
 

 
 

__._,_.___
Recent Activity:
*****************************************
http://in.groups.yahoo.com/group/investwise/

INVESTMENTS IN INDIA
We are low-risk, long-term investors. 

Stocks, mutual funds and the entire investment gamut.  Only financing/investment avenues in India will be discussed. 

For any assistance, questions or improvement ideas, contact investwise-owner@yahoogroups.co.in

****************************************************************

NEW! ==== Check our LINKS and FILES sections for a world of information. REGULARLY UPDATED.

NEW! ==== Check "Tracklist" in Links and Files sections for Investment Ideas.

****************************************************************
.

__,_._,___

**[investwise]** KPMG-Healthcare Trends [1 Attachment]

 
[Attachment(s) from Maverick included below]

FYI

Safe Harbor Statement:

Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.
 
Nothing in this article is, or should be construed as, investment advice.
 
 
 

 
 


--- On Tue, 3/23/10, raunak nagda <ronthedon007@yahoo.co.in> wrote:

From: raunak nagda <ronthedon007@yahoo.co.in>
Subject: report required
To: rajivhanda@yahoo.com
Date: Tuesday, March 23, 2010, 9:15 AM

hi rajiv!!! Thanks for mailing me the reports i required earlier... Do u have a report of KPMG: Health & Healthcare Sector Will Double By 2012, Quadruple By 2017?? Can u mail it 2 be if possible???

Thanks once again!!!!
Raunak


      The INTERNET now has a personality. YOURS! See your Yahoo! Homepage. http://in.yahoo.com/

__._,_.___

Attachment(s) from Maverick

1 of 1 File(s)

Recent Activity:
*****************************************
http://in.groups.yahoo.com/group/investwise/

INVESTMENTS IN INDIA
We are low-risk, long-term investors. 

Stocks, mutual funds and the entire investment gamut.  Only financing/investment avenues in India will be discussed. 

For any assistance, questions or improvement ideas, contact investwise-owner@yahoogroups.co.in

****************************************************************

NEW! ==== Check our LINKS and FILES sections for a world of information. REGULARLY UPDATED.

NEW! ==== Check "Tracklist" in Links and Files sections for Investment Ideas.

****************************************************************
.

__,_._,___

Bonus Issues, Stock Splits, Rights Issues, IPO Updates: Technical Analysis - Raymond

Bonus Issues, Stock Splits, Rights Issues, IPO Updates: Technical Analysis - Raymond


Technical Analysis - Raymond

Posted: 22 Mar 2010 05:27 PM PDT

The password to see buy calls is: LIFEISCOLOURFUL The password to see buy calls is: LIFEISCOLOURFUL Raymond (Rs 237.8): Since the multi-year low of Rs 68 marked in March 2009, the stock has been on an intermediate-term uptrend. However, significant resistance around Rs 250 arrested the stock in January 2010. Short-term investors can hold with target at Rs 250 and stop-loss at Rs [...]

Read More...


Technical Analysis - Suzlon Energy

Posted: 22 Mar 2010 05:05 PM PDT

The password to see buy calls is: LIFEISCOLOURFUL The password to see buy calls is: LIFEISCOLOURFUL Suzlon Energy (Rs 73.9): Suzlon Energy has been trending down from its life-time high of Rs 460 recorded in early January 2008. Moreover, in June 2009 the stock resumed its longer-term downtrend encountering resistance in the band of Rs 140 and 150 and has been on an [...]

Read More...


Coal India IPO in July 2010

Posted: 22 Mar 2010 12:15 PM PDT

The password to see buy calls is: LIFEISCOLOURFUL The password to see buy calls is: LIFEISCOLOURFUL India’s largest coal producer, Coal India Ltd (CIL), expects to hit the capital markets by July. The government, which holds 100 per cent stake in CIL, will divest 10 per cent through an initial public offer (IPO) of 63.1 crore shares. The company will reserve 6.3 crore [...]

Read More...


Re: [sharetrading] ASIA

 
hi abe

am looking to buy Indiabulls real estate today, if it stays below 149.
kindly provide ur view on it. [for a target of  168-170]

or any suggestions....

thanks

Regards
Badrinath M



On Tue, Mar 23, 2010 at 8:17 AM, abrahamputh <abrahamap@airtelmail.in> wrote:
 
Asia seems to be following the DOW, which is steaming ahead full. And as long as the powerhouse is in motion, we all need to remain on/off the bus as per chart indications of indvidual stocks...............
Abe


__._,_.___
 

**[investwise]** Health Reform: The Drug Industry's Big Win!

 
The biggest winner in the historic health reform bill that passed the House late last night are millions of uninsured Americans who are unable to afford  coverage or have been denied coverage because they suffer from chronic disease.
Parsing what the legislation means to industry will take months. But among big businesses,  Pfizer, Amgen and other big drug companies are emerging as big winners.
Drug companies supported health reform and in return will gain access to millions of more customers who suddenly can afford to pay for $100,000 a year cancer drugs. Biotech companies gained an extra layer of protection for protein based drugs from potential generic competition.
The industry avoided its worst fear:  price controls or other new  government drug price negotiations.
The situation is more complicated for HMOs and insurers like UnitedHealth, Wellpoint, and Aetna. They also avoided their worst nightmare, a big public plan that would directly compete with their private plans. That's the good news. 
The bad: some companies will get hit hard by cuts to Medicare Advantage, while others, like Wellpoint, could lose market share in the individual insurance market.

Safe Harbor Statement:

Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.
Nothing in this article is, or should be construed as, investment advice.



__._,_.___
 

**[investwise]** Abbott Labs Completes The Starlims Acquisition

 

Abbott Laboratories said Monday it completed its purchase of Starlims Technology, which makes software used to manage laboratory testing.
Abbott agreed to buy Starlims in December for $123 million, or $14 per share. The company said it bought Hollywood, Fla., company to increase its position in the diagnostic testing market.

Safe Harbor Statement:

Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.
Nothing in this article is, or should be construed as, investment advice.



__._,_.___
 

**[investwise]** KPMG: Health & Healthcare Sector Will Double By 2012, Quadruple By 2017

 

KPMG
Health Care: Blue Skies Scenario
Against a world average of around four hospital beds per 1000 population, India lags behind at just over 0.72. This is a clear indication of the insufficiency of healthcare infrastructure in India.
 
With a population of over a billion, the coordination and strategic choices concerning expenditures on healthcare infrastructures are of vital importance. These are especially challenging given the complex migration patterns typically seen within emerging economies. It remains to be seen how the policies currently in place will shape the Indian healthcare infrastructure market in the future.
 
Private healthcare capacity in India is already significant. Given the anticipated incentives to be offered by the government, including the use of user fee financed  provision and the opportunities for Public Private Partnerships (PPP), it is believed that the private sector market will attract further foreign investment.
 
Additionally, the recent election victory of the United Progressive Alliance (UPA)
with a stable majority, may help provide a mandate to push through major social infrastructure improvements for this emerging global economic power.
 
The Indian healthcare industry is estimated to double in value by 2012 and more than quadruple by 2017. The main factors propelling this growth are rising income levels, changing demographics and illness profiles, with a shift from chronic to lifestyle diseases. This is likely to result in considerable infrastructure challenges and opportunities.
 
• There is growing appreciation for the role private involvement may have in meeting
public demand, and government are looking into the use of PPP models to help improve infrastructure and healthcare provision. The government is also exploring setting up state funded healthcare insurance schemes to support healthcare delivery for the poorer sections of the population. For investment to be effective, the provision of healthcare infrastructure and insurance should be strategically coordinated.
 
• Unlike in developed markets, where there is a focus on generating specialized healthcare facilities and innovations to drive improvements in health services, the Indian healthcare delivery model (including use of PPP) has to date only had success in the provision of more healthcare services in relatively small segments.
 
The challenge remains to develop scalable and sustainable healthcare delivery models to deal with India's diversity and changing socio-economic population profiles. The major innovation in Indian healthcare delivery models needs to be focused on developing and delivering low cost, affordable, basic healthcare services. 
 
Model Outputs
 
• Based on the outputs of our econometric model expenditure on healthcare infrastructure across the Indian states is projected to grow by an average of 5.8 percent per annum between 2009 and 2013, taking the total expenditure in 2013 to US$14.2 billion.
 
• Of the 32 states considered, the six states of Maharashtra, Rajasthan, West Bengal, Uttar Pradesh, Tamil Nadu and Andra Pradesh are forecast to represent approximately 50 percent of the expenditures for the 2009-2013 period
 
• Of the larger states, expenditure on healthcare infrastructure is expected to grow the fastest in Kerala, Rajasthan, and West Bengal.
 
The Indian healthcare industry is estimated to double in value by 2012 and more than quadruple by 2017. The main factors propelling this growth are rising income levels, changing demographics and illness profiles with a shift from chronic to lifestyle diseases.
 
This is likely to result in considerable infrastructure challenges and opportunities.
 
Indian healthcare infrastructure over the last decade has not kept pace with growth in population. The available capacity has increased but not in line with rising demand. This is likely to be in part due to lack of capacity building in semi urban and rural areas.
 
The Indian healthcare system is controlled by respective state authorities, presenting an opportunity to improve responsiveness to healthcare needs at a more local level.
 
Our analysis suggests that there is uneven focus on healthcare infrastructure in India. The variety of organizational structures and processes in healthcare delivery may result in greater inequalities between geographical areas.
 
There is a growing agenda to deal with the issues of urban healthcare infrastructure as rural to urban migration has significantly increased demand for these services.
 
The healthcare sector in India is undergoing considerable reform prompted by the continuing phase of rapid economic growth. Emerging markets, such as diagnostic chains and medical device manufacturers, are attracting increasing amounts of  investment.
 
There is growing appreciation for the role private involvement may have in meeting public demand and government is piloting the use of PPP models to help improve infrastructure and healthcare provision.
 
 
 
Safe Harbor Statement:

Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.
Nothing in this article is, or should be construed as, investment advice.



__._,_.___
 

[sharetrading] ASIA

 
Asia seems to be following the DOW, which is steaming ahead full. And as long as the powerhouse is in motion, we all need to remain on/off the bus as per chart indications of indvidual stocks...............
Abe

__._,_.___
 

[stock_win_india] *IMP - Buy Recommendations and Technical Analysis Calls*

 

Here are some buy calls and technical analysis posts, check them out below. Join and SUBSCRIBE 5400+ subscribers community who are getting daily updates like these from us.

Meanwhile, would you please check out these free offers below and register:

The stock is trading at a significant discount to the value of its investment book, which comprises mainly of Tata Group companies. TIC is a good defensive option with low volatility, as the stock's beta against the BSE 500 is 0.43. This, coupled with steep discount to the underlying book value, reduces downside.

An improved balance-sheet, presence in the lucrative redevelopment Mumbai market and willingness to quickly shed stake in large projects to keep the cash clock ticking are key positives for Orbit Corporation. These factors are likely to aid the company achieve superior earnings growth over the next two years.

Suzlon Energy (Rs 73.9): Suzlon Energy has been trending down from its life-time high of Rs 460 recorded in early January 2008. Moreover, in June 2009 the stock resumed its longer-term downtrend encountering resistance in the band of Rs 140 and 150 and has been on an intermediate downtrend. The short-term trend is sideways in the range of Rs 68 and Rs 82. This trend can prolong further in the near-term. A downward breakthrough will pull the stock to Rs 55, November 2009 troughLong-term investors can continue to hold with stop at Rs 53. However, a conclusive upward penetration of the range would lead the stock to Rs 90 and then Rs 105 in the long-term.

Raymond (Rs 237.8): Since the multi-year low of Rs 68 marked in March 2009, the stock has been on an intermediate-term uptrend. However, significant resistance around Rs 250 arrested the stock in January 2010. Short-term investors can hold with target at Rs 250 and stop-loss at Rs 220. Medium-term and long-term investors can continue to holdthe stock with stop at Rs 206 and Rs 178 respectively. Decisive break-out of the resistance would reinforce the bullish momentum and liftthe stock higher to Rs 300 or Rs 336 in the long-term


Thanks,
Stock Market Investor

Add to Yahoo: stockmarketindia24
Follow me on twitter - http://twitter.com/smi24

__._,_.___
Recent Activity:
.

__,_._,___

Indian Stocks BSE

Indian Stocks BSE


PICCADILY AG ( 530305 )

Posted: 22 Mar 2010 05:32 AM PDT

Free Intraday Cash Tips from Tipz.in for 23rd March 10
530305 Chart ( PICCADILY AG)
Action Trigger Price Stop LossTarget 1 Target 2
BUY ABOVE19.819.620.821.6
S.SELL BELOW19.419.71917.9
523144 Chart ( MEDI CAPS )
Action Trigger Price Stop LossTarget 1 Target 2
BUY ABOVE6967.97479
S.SELL BELOW6768.563.557.5
509960 Chart ( U.P.HOTELS )
Action Trigger Price Stop LossTarget 1 Target 2
BUY ABOVE212210220228
S.SELL BELOW209211203193


VALIANT COMM ( 526775 )

Posted: 22 Mar 2010 05:30 AM PDT

Hot Stocks from Tipz.in for 23rd March 10
526775(VALIANT COMM), 530305(PICCADILY AG), 511072(DEWAN H.FIN.),
524711(VISTA PHARMA), 590030(SOUTH PET(PS), 523850(AXTEL INDUS.),
506172(SAMPADA CHEM), 532755(TECH MAH ), 509960(U.P.HOTELS ),
523144(MEDI CAPS ), 532411(VISESH INFO.), 531272(NIKKI GLOBAL).